dr. pal on sequencing challenges for the treatment of patients with rcc
Published 7 years ago • 106 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
0:43
dr. pal on sequencing nivolumab in rcc
-
0:48
dr. pal on preoperative immunotherapy in patients with rcc
-
0:57
dr. jonasch on sequencing challenges in rcc
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
1:03
dr. pal on the sequencing of immunotherapy for urothelial carcinoma
-
38:47
renal cell carcinoma
-
4:55
the diagnosis of a patient with stage 4 renal cell cancer
-
6:10
kidney cancer symptoms, diagnosis and treatment
-
0:54
dr. lee on sequencing therapies for patients with rcc
-
0:48
dr. pal discusses the role of pd-l1 in metastatic rcc
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
0:51
dr. pal on the frontline approval of nivolumab and ipilimumab in mrcc
-
0:53
dr. chowdhury on sequencing of immunotherapy regimens for rcc
-
1:52
dr. powles on monitoring immunotherapy effects in patients with rcc
-
1:33
dr. pal on the checkmate-214 and cabosun studies in rcc
-
8:40
advanced rcc sequencing challenges
-
0:58
dr. pal on an enrolling clinical trial for patients with gu cancers
-
2:00
dr. pal on adjuvant therapy of renal cell carcinoma
-
1:14
dr. jonasch on the cabosun trial in rcc
-
0:53
dr. jonasch on the potential of immunotherapy for sarcomatoid rcc